Related information
by Kogushi, M. et al.Eisai Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, JapanThe novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial...
View ArticleRelated information
by Altarescu, G. et al.Genetics Unit, Shaare Zedek Medical Center, IsraelThe [-1426(C/T)] polymorphic variant of PAR1 is associated with thrombocytopenia in Gaucher disease.Blood Cells Mol. Dis. 2010;...
View ArticleRelated information
by Bae, J.S. et al.Edward A Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St Louis, Missouri 63104, USAFactor X/Xa elicits protective signaling...
View ArticleRelated information
by Silini, A. et al.Laboratory of Biology and Treatment of Metastases, Department of Oncology, Mario Negri Institute for Pharmacological Research, Milan, ItalyThe migration and invasion capabilities...
View ArticleRelated information
by McCoy, K.L. et al.Department of Pharmacology, Rollins Research Center, Emory University School of Medicine, Atlanta, USAPAR1 effects on ERK1/2 phosphorylation and cell migration were blocked both...
View ArticleRelated information
by Smadja, D.M. et al.Université Paris Descartes, Faculté de Pharmacie, Paris, FranceTarget-specific siRNA-induced PAR-1 knockdown, and fully inhibited PAR-1-induced IL-8 synthesis.J. Cell. Mol. Med....
View ArticleRelated information
by Banfi, C. et al.Monzino Cardiologic Center IRCCS, Milan, ItalyMitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial...
View ArticleRelated information
by Hernández, N.A. et al.Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, MexicoTwenty-nine of 50 (58%) patients overexpressed PAR1, and 23 of these (46%)...
View ArticleRelated information
by Grisaru-Granovsky, S. et al.Department of Oncology, Hadassah-University Medical Center, Jerusalem, IsraelProtease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin...
View ArticleRelated information
by Chintala, M. et al.Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USAPreclinical and clinical studies have confirmed that SCH 530348, a potent, orally active...
View ArticleRelated information
by Gudmundsdóttir, I.J. et al.Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United KingdomRole of the endothelium in the vascular effects of the thrombin receptor...
View ArticleRelated information
by Gigante, B. et al.Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Division of Pharmacology, Federico II University, ItalyRetrospective analysis of coagulation factor II...
View ArticleRelated information
by Loberg, R.D. et al.Department of Urology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USAFurther exploration is needed to determine whether PAR1 activation...
View Article
